Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
A.2.5.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AZ.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.270NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.227NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
U.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.36.28NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.43.2 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.258.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.50 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.266NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.253NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.305NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AA.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.241NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.33NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.326NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.255NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.303NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AA.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.173NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.362.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.48NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.36.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.520NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.36.38NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.521NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.383NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.117NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.157NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.187NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.30NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.213NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.12NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.341NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.89NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.36.23NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.30NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.379NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.240NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.240.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.121.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1923.32South Korea
B.1.1.46NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.44NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.389NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.549NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.558NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.518NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used